Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate ESSA Pharma Inc. before investing.

In this article, we go over a few key elements for understanding ESSA Pharma Inc.’s stock price such as:

• ESSA Pharma Inc.’s current stock price and volume
• Why ESSA Pharma Inc.’s stock price changed recently
• Upgrades and downgrades for EPIX from analysts
• EPIX’s stock price momentum as measured by its relative strength

About ESSA Pharma Inc. (EPIX)

Before we jump into ESSA Pharma Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.

Want to learn more about ESSA Pharma Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about ESSA Pharma Inc..

ESSA Pharma Inc.’s Stock Price as of Market Close

As of April 16, 2025, 12:31 PM, CST, ESSA Pharma Inc.’s stock price was $1.859.

ESSA Pharma Inc. is up 14.04% from its previous closing price of $1.630.

During the last market session, ESSA Pharma Inc.’s stock traded between $1.700 and $1.880. Currently, there are approximately 44.39 million shares outstanding for ESSA Pharma Inc..

ESSA Pharma Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

ESSA Pharma Inc. Stock Price History

ESSA Pharma Inc.’s (EPIX) price is currently up 17.65% so far this month.

During the month of April, ESSA Pharma Inc.’s stock price has reached a high of $1.880 and a low of $1.420.

Over the last year, ESSA Pharma Inc. has hit prices as high as $7.880 and as low as $1.400. Year to date, ESSA Pharma Inc.’s stock is up 3.85%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused ESSA Pharma Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of April 15, 2025,, no analysts have changed their rating of ESSA Pharma Inc.’s stock over the last month.

Additionally, you'll want to evaluate ESSA Pharma Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on ESSA Pharma Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about ESSA Pharma Inc. (EPIX) by visiting AAII Stock Evaluator.

Relative Price Strength of ESSA Pharma Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 15, 2025, ESSA Pharma Inc. has a weighted four-quarter relative price strength of -18.80%, which translates to a Momentum Score of 14 and is considered to be Very Weak.

Want to learn more about how ESSA Pharma Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

ESSA Pharma Inc. Stock Price: Bottom Line

As of April 16, 2025, ESSA Pharma Inc.’s stock price is $1.859, which is up 14.04% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like ESSA Pharma Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.